Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products - PubMed (original) (raw)
. 2006 Dec;44(12):2033-9.
doi: 10.1016/j.fct.2006.07.003. Epub 2006 Jul 10.
Affiliations
- PMID: 16904803
- DOI: 10.1016/j.fct.2006.07.003
Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products
Naoko Yoshida et al. Food Chem Toxicol. 2006 Dec.
Abstract
Terpenoids form a large and structurally diverse family of natural products and are ingredients of various herbal medicines. We have investigated possible interactions between herbal medicines and conventional medicines, and recently reported that monoterpenoids contained in Zanthoxyli Fructus can be potent inhibitors of P-glycoprotein (P-gp). In the present study, the influence of 70 kinds of terpenoids present in natural products on P-gp-mediated efflux transport was investigated. LLC-GA5-COL150 cells transfected with human MDR1 cDNA encoding P-gp were used to screen the terpenoids. Large increases in the intracellular accumulation of [(3)H]digoxin were observed in the presence of (R)-(+)-citronellal, (S)-(-)-beta-citronellol, alpha-terpinene, terpinolene, (-)-beta-pinene, abietic acid, ophiobolin A, cucurbitacin I, and glycyrrhetic acid. A study of the concentration-dependency revealed that the IC(50) of ophiobolin A, glycyrrhetic acid, (R)-(+)-citronellal, abietic acid, and cucurbitacin I was smaller than that of verapamil. The transcellular transport of [(3)H]digoxin across Caco-2 cell monolayers was then examined in the presence of (R)-(+)-citronellal, abietic acid, and glycyrrhetic acid. Significant increases in the apical-to-basolateral transport and decreases in the basolateral-to-apical transport and efflux ratio were demonstrated. These findings suggest that some natural products containing these terpenoids may inhibit P-gp-mediated transport and interact with P-gp substrates in the intestinal absorption process.
Similar articles
- Inhibition of P-glycoprotein-mediated transport by extracts of and monoterpenoids contained in Zanthoxyli fructus.
Yoshida N, Takagi A, Kitazawa H, Kawakami J, Adachi I. Yoshida N, et al. Toxicol Appl Pharmacol. 2005 Dec 1;209(2):167-73. doi: 10.1016/j.taap.2005.04.001. Toxicol Appl Pharmacol. 2005. PMID: 15890377 - Inhibitory effects of terpenoids on multidrug resistance-associated protein 2- and breast cancer resistance protein-mediated transport.
Yoshida N, Takada T, Yamamura Y, Adachi I, Suzuki H, Kawakami J. Yoshida N, et al. Drug Metab Dispos. 2008 Jul;36(7):1206-11. doi: 10.1124/dmd.107.019513. Epub 2008 Apr 24. Drug Metab Dispos. 2008. PMID: 18436619 - Effects of citronellal, a monoterpenoid in Zanthoxyli Fructus, on the intestinal absorption of digoxin in vitro and in vivo.
Yoshida N, Takagi A, Kitazawa H, Kawakami J, Adachi I. Yoshida N, et al. J Pharm Sci. 2006 Mar;95(3):552-60. doi: 10.1002/jps.20563. J Pharm Sci. 2006. PMID: 16419049 - P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions.
Kumar YS, Adukondalu D, Sathish D, Vishnu YV, Ramesh G, Latha AB, Reddy PC, Sarangapani M, Rao YM. Kumar YS, et al. Drug Metabol Drug Interact. 2010;25(1-4):3-16. doi: 10.1515/DMDI.2010.006. Drug Metabol Drug Interact. 2010. PMID: 21417789 Review. - Inhibition of tumor progression by naturally occurring terpenoids.
Kuttan G, Pratheeshkumar P, Manu KA, Kuttan R. Kuttan G, et al. Pharm Biol. 2011 Oct;49(10):995-1007. doi: 10.3109/13880209.2011.559476. Pharm Biol. 2011. PMID: 21936626 Review.
Cited by
- A lavender ABC transporter confers resistance to monoterpene toxicity in yeast.
Demissie ZA, Tarnowycz M, Adal AM, Sarker LS, Mahmoud SS. Demissie ZA, et al. Planta. 2019 Jan;249(1):139-144. doi: 10.1007/s00425-018-3064-x. Planta. 2019. PMID: 30535718 - Lack of effect of continuous glycyrrhizin administration on the pharmacokinetics of the P-glycoprotein substrate talinolol in healthy volunteers.
Yan M, Fang PF, Li HD, Xu P, Liu YP, Wang F, Cai HL, Tan QY. Yan M, et al. Eur J Clin Pharmacol. 2013 Mar;69(3):515-21. doi: 10.1007/s00228-012-1391-6. Epub 2012 Sep 15. Eur J Clin Pharmacol. 2013. PMID: 22983284 Clinical Trial. - Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer.
Shen Q, Wang Y, Zhang Y. Shen Q, et al. Int J Nanomedicine. 2011;6:1237-43. doi: 10.2147/IJN.S20903. Epub 2011 Jun 20. Int J Nanomedicine. 2011. PMID: 21753875 Free PMC article. - Mechanisms of drug resistance in nutrient-depleted colorectal cancer cells: insights into lysosomal and mitochondrial drug sequestration.
Köse SG, Güleç Taşkıran AE. Köse SG, et al. Biol Open. 2024 Jul 15;13(10):bio060448. doi: 10.1242/bio.060448. Epub 2024 Oct 24. Biol Open. 2024. PMID: 39445740 Free PMC article. Review. - Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein.
Laiolo J, Graikioti DG, Barbieri CL, Joray MB, Antoniou AI, Vera DMA, Athanassopoulos CM, Carpinella MC. Laiolo J, et al. Sci Rep. 2024 Jan 2;14(1):70. doi: 10.1038/s41598-023-49939-9. Sci Rep. 2024. PMID: 38167542 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous